A retrospective cohort study comparing long-term clinical outcomes between patients with and without neoadjuvant therapy in stage IB–IIB cervical cancer: a propensity score-matched study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: The management of stage IB-IIB cervical cancer (CC) remains a matter of debate. Neoadjuvant therapy (NAT) followed by surgery has emerged as a potential alternative to upfront radical surgery. This study aimed to investigate the survival outcomes of NAT followed by surgery in patients with stage IB-IIB CC, using upfront surgery alone as the comparator. Methods: CC patients who received NAT in Fujian Cancer Hospital between October 2009 and April 2013 were retrospectively enrolled. A 1:1 propensity score matching (PSM) was conducted to select a comparison cohort of surgeries without NAT from the Surveillance, Epidemiology, and End Results Program (SEER) database. Kaplan-Meier and Cox models were used to assess overall survival (OS) between the NAT and non-NAT cohorts, while recurrence-free survival (RFS) was evaluated only in the NAT cohort, as recurrence data were not available in the SEER database. Results: 76.7%) were significantly higher in the NAT cohort than in the non-NAT cohort (P
Fields of Study & Subjects
Endometrial and Cervical Cancer Treatments
Cervical Cancer and HPV Research
Ovarian cancer diagnosis and treatment
Publication details
- Journal / source
- Translational Cancer Research
- Volume
- 15
- Issue
- 3
- Pages
- 201–201
- Publication date
- 1 March 2026
- Language
- EN